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INTRODUCTION
Mushrooms have a scientifi cally confi rmed benefi cial in-
fl uence on human health. This property stretches beyond that 
which can be expected from nutrients found in mushrooms. 
Based upon the chemical composition of edible mushroom 
fruiting bodies, it can be stated that they are a valuable source 
of dietary ingredients necessary for stimulating the develop-
ment and growth of the human organism and sustaining its 
life functions. Agaricus bisporus (J.E. Lange) Imbach – white 
or button mushroom, is mainly available for consumers from 
commercial cultures; it is well known for its taste and aroma. 
The most important qualities of A. bisporus are its dietetic 
and medicinal properties derived from its rich composition 
of metabolites and biologically-active elements. A. bisporus 
is a  rich source of dietary fi ber (chitin), essential and semi-
-essential amino acids, and antioxidant substances (sterols, 
phenolic and indole compounds, ergothioneine, vitamins, se-
lenium) [Elmastas et al., 2007; Foulongne-Orio et al., 2013].
A. bisporus grows in Poland between May and September. 
Usually, it occurs in places fertilized with cow dung, compost 
piles, parks and  forests. Its growth on open spaces is  rare. 
More frequently, it can be cultivated on special culturing sub-
strates [Leiva et al., 2015]. A. bisporus plays an important part 
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in the decomposition of leaves and needles in parks and for-
ests. Apart from its ecological function, it is one of the most 
frequently cultivated mushrooms worldwide. The fi rst known 
information about A. bisporus culturing comes from France 
in 1707 [Elmastas et al., 2007; Foulongne-Orio et al., 2013; 
Glamočlija et al., 2015] and for this reason, the species is also 
widely known as the Paris champignon. 
The aim of the present study was to describe the impor-
tance, dietary value, and medicinal properties of A. bisporus 
fruiting bodies.
THE MAIN GROUPS OF BIOLOGICALLY-ACTIVE 
SUBSTANCES IN AGARICUS BISPORUS
Amino acids in fruiting bodies of Agaricus bisporus
Fruiting bodies of A. bisporus are a rich source of amino 
acids (essential, semi-essential, and  non-essential). Eigh-
teen of these compounds were researched and described, but 
some are not present in  suffi ciently high amounts to make 
A. bisporus a  source for supplementation. The amino acids 
found in A. bisporus in the highest amounts are alanine, as-
partic acid, glutamic acid, arginine, leucine, lysine, phenyl-
alanine, serine, proline, tyrosine and threonine [Bernaś et al., 
2006a; Muszyńska et al., 2013a]. On the other hand, cysteine, 
methionine and valine are the  least abundant [Bernaś et al. 
2006b]. Liu et al. [2013] determined the total content of free 
amino acids as 70.55 mg/g dry weight (D.W.). Arginine pres-
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White Agaricus bisporus is both the most popular and the most commonly eaten edible mushroom species in the world. It is popular not only be-
cause of its taste, but also due to its high level of nutrients: dietary fi ber (chitin), essential, semi-essential amino acids, unsaturated fatty acids including 
linoleic and linolenic acids, easily digestible proteins, sterols, phenolic and indole compounds, and vitamins − especially provitamin D2 and B1, B2, B6, 
B7, and C. Fruiting bodies of A. bisporus have antioxidant, antibacterial, anti-infl ammatory, antitumor, and immunomodulatory activity. The presence 
of antioxidant ergothioneine (which also displays the antimutagenic, chemo- and radioprotective activity) is also noteworthy. A. bisporus also contains 
derivatives of benzoquinone, a substance which belongs to the group of antibiotics. Studies of tyrosinase isolated from this species show its very high 
similarity to human tyrosinase. This points directly to the fact that this species could be a rich source of tyrosinase used for medicinal and cosmetics 
purposes. A. bisporus is also a rich source of selenium, zinc and other elements such as magnesium, copper, iron, potassium, sodium, calcium, phos-
phorus, sulfur or manganese. In conclusion, the presence of these compounds and elements with biological activity in fruiting bodies of A. bisporus 
confi rms their nutraceutical and medicinal properties.
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ent in the Agaricales taxon should be given special attention 
– because it is a component used in dietary supplements for 
patients with cancer. Arginine delays tumor growth and me-
tastasis, and also has a benefi cial infl uence on the immunolog-
ical system, body mass growth and the life-expectancy of on-
cological patients [Novaes et al., 2011]. In  further research, 
it was shown that the processes of production and  storage 
(the most popular are drying, preserving in air tight contain-
ers, salting and  freezing) of  A. bisporus decrease the  total 
content of amino acids in this species. The decrease in amino 
acid concentrations after six months of  storage ranged be-
tween 40% and 90% and depended on the processing method 
[Bernaś et al., 2006b]. Pei et al. [2014] determined free amino 
acids in fruiting bodies of A. bisporus and their content ranged 
from 0.8 to 14.1 mg/g D.W. The total content of free amino 
acids was up to 44.2 mg/g D.W. [Pei et al., 2014]. The detailed 
information is to be found in Table 1.
Saccharides in Agaricus bisporus fruiting bodies
Mushrooms are characterized by high contents of mono-
saccharides, disaccharides and polysaccharides. Research has 
shown that the total content of carbohydrates in fruiting bod-
ies of white mushroom ranges between 4.5 and 4.6% of fresh 
weight or 51.3 and 62.5% dry weight (Table 1). A. bisporus 
is also a rich source of fi ber which benefi cially affects the di-
gestive tract. Although the cell walls of plants are usually con-
sidered a main source of dietary fi ber – mushrooms can also 
assume this function. Mushroom cell walls contain a mixture 
of fi bers and matrix components that are rich in chitin (a cross-
linked polymer of N-acetylglucosamine) and other polysac-
charides such as β-D-glucans and mannans [Cheung, 2013; 
Liu et al., 2013]. Apart from its role in the metabolism, dietary 
fi ber from mushrooms plays an important role in the regula-
tion of lipid levels, and decreasing levels of low density lipo-
protein (LDL) and total cholesterol without interfering with 
high density lipoprotein concentrations (HDL) [Cheung, 
2013; Muszyńska et  al., 2013a; Rajewska & Bałasinska, 
2004]. The mechanism of  this phenomenon is  not entirely 
clear, but it has been proven that the fi ber from mushrooms 
can be an alternative to that originating from other foodstuffs. 
A hypocholesterolemic effect can be caused by impaired ab-
sorption in the digestive tract due to dietary fi ber presence, or 
by  the  infl uence of  intestinal or pancreatic secretion. Other 
possible mechanisms include an indirect infl uence on li-
poproteins or the bile acid metabolism. Considering a high 
content of dietary fi ber and a low content of fat, A. bisporus 
may become a dietary component that prevents atheroscle-
rosis [Fukushima et al., 2000]. Chitin and chitosan are com-
monly used in  the pharmaceutical industry. Apart from be-
ing adjuvant in many drugs, these substances are ingredients 
of many slimming preparations. The slimming effect occurs 
due to decreased absorption of lipids from food. The effi cacy 
of chitosan was researched with two groups of volunteers on 
a low fat diet. Patients regularly taking chitosan reduced their 
weight considerably more quicker. The chitosan group lost, 
on average, 7 kg and the patients from the control group lost 
only 3 kg [Rajewska & Bałasińska, 2004]. Apart from a ben-
efi cial infl uence on fat metabolism and body weight decrease, 
the research also showed an improvement in sugar metabo-
lism. Consumption of A. bisporus caused a 24.7% decrease 
in glucose levels in type II diabetic rats. A similar positive ef-
fect was obtained in rats with hypercholesterolemia, in which 
a decrease in LDL and  total cholesterol was noted as well 
as an increase in HDL cholesterol fraction [Czapski, 2005; 
Jeong et al., 2010].
Apart from their antimicrobial activity, chitin and chito-
san are also used in wound dressings. Their action involves 
local pain relief (due to separating pain receptors from envi-
ronmental exposure), wound healing enhancement and pre-
vention of scaring [Rajewska & Bałasinska, 2004]. An impor-
tant property of chitosan – its blood clotting ability – has been 
used in hemorrhaging wound dressings. Chitosan can work 
without setting up a normal blood clotting cascade. Unfor-
tunately, its effectiveness has been questioned due to its low 
adhesion abilities. New animal trials suggest that modifi ed 
chitosan with higher bioadhesive abilities will be signifi cantly 
more effective in wound treatment [De Castro et al., 2012]. 
Currently, dressings based on chitosan are used in military 
medicine – even for very severe combat injuries. Chitosan-
-based dressings were used by the US army during the Iraqi 
intervention. There have been promising results from new 
experiments into the use of chitosan in dental surgery where 
parts of military dressings were used for hemorrhages during 
teeth extraction [Bennett & Littlejohn, 2014; Malmquist et al., 
2008].
Trehalose, a  disaccharide found in  A. bisporus (with 
the  content ranging from 1% to 3% D.W.), is metabolized 
to glucose in  the  human organism. It  stimulates enzymes 
responsible for the stabilization of protein structures during 
chemical and thermal denaturation. In mushrooms, trehalose 
acts as a carbohydrate reservoir and protects the mushroom 
from extreme environmental conditions such as temperatures, 
osmotic stress or radiation. Mushrooms are also rich in sugar 
alcohols such as mannitol (5–30% D.W.) [Gheibi et al., 2006; 
Malmquist et al., 2008; Wannet et al., 1998]. Pei et al. [2014] 
found the  content of mannitol in  fresh fruiting bodies at 
121 mg/g and that for trehalose at 12.1 mg/g. These research-
ers examined whether the  freeze drying infl uenced the  level 
of  these compounds and  found decreased contents of  these 
sugars after the freeze drying process. 
Fucogalactan from A. bisporus (EFP-Ab) presented a new 
class of mushroom metabolites with anti-infl ammatory ac-
tivity as a result of suppressed iNOS and COX-2 expression 
[Ruthes et al., 2013]. 
A. bisporus contains a  linear (1→6)-β-d-glucan that can 
be  isolated by DMSO extraction. This compound inhibits 
the expression of pro-infl ammatory genes and reduces LPS-
-induced infl ammation by inhibition of IL-1 and COX-2 pro-
teins [Smiderle et al., 2013].
Lectins from fruiting bodies of A. bisporus and  their 
antiproliferative activity
Lectins are the next group of therapeutically-active com-
pounds found in A. bisporus fruiting bodies and mycelium 
from in  vitro cultures. Lectins are conjugates of  proteins 
(mainly storage proteins) and saccharides produced by mush-
rooms and plants. It has been proven that the role of lectins 
is more complicated in mushrooms than in plants [Hassan 
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et  al., 2015]. These substances are involved in  numerous 
processes on a molecular and cell level. In higher mushroom 
species such as the white mushroom, lectins may play vari-
ous roles depending on growth phase or environmental con-
ditions. Lectins are storage proteins intervening in  growth, 
development and morphogenesis phases. Some are involved 
in  important functions of mushroom metabolism such as 
mycorrhiza or parasitic dependencies with other organisms. 
Lectins may protect the mushrooms from toxins coming from 
the environment, such as pesticides or bacteria [Ng, 2004]. 
Lectins, particularly those from edible mushrooms, have at-
tracted the  attention of  the  academic community, because 
their immunomodulatory activity comes from an accelera-
tion of  immunological cell maturation and a potential anti-
cancer activity. The anticancer effect is possible due to the 
 anti-proliferative infl uence of lectins of A. bisporus (ABL) on 
endothelial carcinoma cells, without inducing the  cytotoxic 
effect [Carrizo et al., 2005; Singh et al., 2015]. Lectins from 
A. bisporus are also capable of inhibiting the reverse transcrip-
tase of HIV1, which stops virus replication in host cells [Wang 
& Ng, 2001]. ABL have been researched as active compounds 
in psoriasis (because it is a disease originating from excessive 
proliferation of human keratocytes) [Yu et al., 1999]. Applica-
tion of lectins stops further cell divisions without any cytotoxic 
effect on endothelium cells [Parslew et al., 1999]. Lectins have 
also been examined as active in vitreoretinopathy and other 
eye diseases involving wound healing impairment. The ABL 
slow retina contractions and adhesion of human pigmenta-
tion cells to retina endothelium, also without any cytotoxic 
effect. During clinical trials, lectins have shown strong anti-
proliferative action against epithelial cells of the retina, which 
could directly reduce retinal detachment [Kent et al., 2003ab; 
Wang et al., 2012]. The ABL show the anti-proliferative ac-
tion towards numerous types of cells. One in vitro experiment 
was conducted to confi rm the inhibitory effect of ABL on fi -
broblasts found in the Tennon capsule. An increase in wound 
healing was shown, which furthermore led to the  applica-
tion of ABL in  controlling scaring after surgical glaucoma 
treatment [Batterbury et  al., 2002]. Lectins have also been 
examined as potentially anti-diabetic substances effective 
both in prophylaxis and  treatment. This effect comes from 
lectins capability to enhance the divisions of β cells in pan-
creatic islets. Some studies have been performed to determine 
the degree of regeneration on β cells in mice and to describe 
the mechanisms of their proliferation. The analysis was con-
ducted based on glucose measurements and insulin secretion 
levels after administration of mushroom lectins. It was shown 
that lectins from A. bisporus decreased blood glucose levels 
[Ahmad et al., 1984; Jeong et al., 2010].
Indole compounds in  fruiting bodies of  Agaricus 
bisporus
Recent research has proven that A.  bisporus contains 
non-hallucinogenic indole compounds [Muszyńska et  al., 
2015a, b]. Indole compounds have a benefi cial infl uence on 
the human organism and play an important role in numerous 
metabolic pathways – as neurotransmitters or their precur-
sors. Indoles are important compounds due to their anti-
-cancer and  anti-aging activity; these compounds regulate 
cell cycles and blood clotting. The pharmacological profi le 
of  these compounds also includes their antioxidant activ-
ity. The fruiting bodies of A. bisporus contain L-tryptophan, 
5-hydroxy-L-tryptophan, melatonin, serotonin, tryptamine, 
and 5-methyl-tryptamine [Muszyńska et al., 2013b]. The re-
search conducted by Muszyńska describes the amount of in-
dole compounds extracted from A. bisporus to artifi cial gastric 
juice. This research showed how much of each indole com-
pound is  released from white mushroom fruiting bodies or 
in vitro cultures in the conditions of the human digestive tract. 
The fruiting bodies were obtained from a commercial source 
and the in vitro cultures from liquid cultures on Oddoux me-
dium (both standard and  enriched in zinc hydroaspartate). 
Four indole compounds were identifi ed and assayed: 5-hy-
droxy-L-tryptophan, L-tryptophan, serotonin, and  5-meth-
yl-tryptamine. A. bisporus could be a good source of  indole 
compounds [Muszyńska et  al., 2015a, b]. The  contents 
of  indole compounds in  fruiting bodies range from 0.06  to 
6.21 mg/100 g D.W. (Table1). The highest content has been 
reported for kynurenic acid [Muszyńska et al., 2011].
Phenolic compounds in  fruiting bodies of  Agaricus 
bisporus
Phenolic acids are the major representatives of the phe-
nol compounds present in mushrooms. They exhibit a wide 
spectrum of biological activities which have been attributed 
to their strong antioxidant activity and ability to protect vital 
cellular structures, such as cell membranes, and also struc-
tural proteins, enzymes, membrane lipids or nucleic acids. 
Gallic, caffeic, ferulic, p-coumaric, and protocatechuic acids 
are found in  fruiting bodies of A. bisporus. They are char-
acterized by antioxidant, antibacterial, antiviral, antifungal, 
anti-infl ammatory, and gastric-secretion stimulatory actions, 
documented by  in  vitro and  in  vivo studies [Czapski, 2005; 
Labus et al., 2011; Liu et al., 2013]. In addition, protocat-
echuic acid has been shown to possess immunomodulating, 
spasmolytic, cardioprotectant, anticoagulant, and  chemo-
preventive properties [Wee, 2010]. The  contents of pheno-
lic compounds in  fruiting bodies of A. bisporus range from 
2.31 mg/kg D.W. for p-coumaric acid to 2729 mg/kg D.W. 
for myricetin [Czapski, 2005; Labus et al., 2011; Liu et al., 
2013]. A positive correlation between microbial inhibitions 
and the total content of phenolic compounds in ethanol ex-
tracts from fruiting bodies of A. bisporus was presented in an 
Australian research [Ndungutse et  al., 2015]. The  content 
of phenolic compounds in A. bisporus fruiting bodies is pre-
sented in Table 1.
Tyrosinase from fruiting bodies of  Agaricus bisporus 
and its properties
The pharmacological properties and application of white 
mushrooms are connected with the process of melanogenesis 
in  the human organism. Melanogenesis – the biosynthesis 
of the pigment melanin in the skin – is catalyzed by tyrosi-
nase. Since the discovery of this enzyme, research has been 
undertaken in  order to fi nd a  good natural source of  this 
substance. It has been found that A. bisporus naturally con-
tains large quantities of  this compound. Tyrosinase acts as 
a catalyst in the hydroxylation of monophenol and the oxi-
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dation of  diphenol in  the  presence of  atmospheric oxygen 
[Kampmann et  al., 2015; Labus et  al., 2011; Zaidi et  al., 
2014]. It has also been shown that tyrosinase isolated from 
A. bisporus may catalyze bisphenol reactions, which could 
make this species a useful bioremediation agent [Kampmann 
et al., 2015]. Tyrosinase plays an important role in the syn-
thesis of melanin in melanocytes found in epidermis and cells 
from the neural crest. This enzyme was described for the fi rst 
time in mammals [Bloch, 1927]. Its connection with the de-
velopment of melanoma has been described, as well as its 
link to skin pigmentation problems (such as vitiligo or albi-
nism) [Zaidi et al., 2014]. Tyrosinase can be extracted from 
various sources, i.e. mushrooms and  fruits. In mushrooms, 
melanin is  involved in numerous defense mechanisms that 
protect mushrooms from various stress factors such as UV 
or gamma radiation, free radicals, dehydration or extreme 
temperatures. The stability of mushroom spores is also de-
rived from the  protective action of melanin. Furthermore, 
tyrosinase has a  role in wound healing and  immunological 
response in plants. In humans, tyrosinase is involved in me-
lanocyte pigmentation processes; it  is also a marker in me-
lanoma patients and  takes part in  the prodrug metabolism 
[Labus et al., 2011; Zaidi et al., 2014]. Research on tyrosinase 
isolated from white mushrooms has shown a high similar-
ity to human tyrosinase. It suggests that this species could 
be  a  rich source of  tyrosinase for medicinal and  cosmetic 
purposes [Labus et al., 2011; Zaidi et al., 2014]. Tyrosinase 
is a thermolabile protein. It shows a protective effect towards 
Raji cells (human lymphoma cell line), preventing oxidative 
DNA damage. A. bisporus species shows a protective effect to 
DNA isolated from lymphocytes taken from rats into which 
mushroom extracts have been injected intraperitoneally. 
The genoprotective effect of tyrosinase has been determined 
by gel electrophoresis of single cells and cell damage extent 
after application of stress generating factors was evaluated. 
In  the  test, enzymatic hydroxylation of  tyrosine occurred, 
leading to levodopa and then a conversion to dopaquinone. 
The protective potential of oxidative damage depends on ty-
rosinase, which is a fi rst link in the tyrosine reaction pathway. 
This is  not an effect of  oxidant inactivation but levodopa 
conversion, which is possible due to the catalytic action of 
A. bisporus tyrosinase [Shi et al., 2002].
Ergothioneine in  fruiting bodies of Agaricus bisporus 
and their antioxidant activity
The antioxidant action of A. bisporus is  connected with 
a  histidine derivative – ergothioneine. Ergothioneine is  a 
 water-soluble compound found in  some mycobacteria 
and molds and  it  is  not synthesized by  animals, in which 
it is important for proper functioning. These organisms eas-
ily absorb ergothioneine and  store it  in  cells that are espe-
cially susceptible to oxidative stress. The  highest amount 
of this substance can be found in erythrocytes, the eye lens, 
semen, and skin. Its most important feature is the ability to 
reduce lesions due to irradiation, hypoxia (from transplan-
tations), heart attack or brain stroke. Ergothioneine is a key 
substrate for organic cation transporters (OCTN1) and plays 
a protective role for monocytes. A decreased level of  these 
cells and  their improper differentiation is  characteristic for 
auto-immunological diseases such as rheumatoid arthritis or 
Crohn’s disease. Apart from its antioxidant action, ergothio-
neine also shows antimutagenic, chemo- and radioprotective 
activity, which makes it an important medical substance [Chen 
et al., 2012; Muszyńska et al., 2013a]. The content of ergo-
thioneine found in  fruiting bodies of A. bisporus by Dubost 
et al. [2007] was at 0.21 mg/g D.W. Chen et al. [2012] stated 
that the content of  this compound was higher and  reached 
up to 0.93 mg/g D.W. These data show that A. bisporus is one 
of the best sources of this compound [Chen et al., 2012].
Fruiting bodies of A. bisporus as a source of lovastain
One of the most signifi cant compounds found in fruiting 
bodies of A. bisporus is lovastatin –– an approved-to-market 
drug used in  the  treatment of hypercholesterolemia –– that 
acts as an inhibitor of HMG-CoA reductase. The  highest 
content of  lovastatin (565.4 mg/kg D.W.) has been found 
in fruiting bodies of mature mushrooms [Chen et al., 2012].
Fruiting bodies of A. bisporus as a source of agaritine
Agaritine has been claimed to be  a  weak carcinogen. 
It  was shown to induce adenomas and  adenocarcinomas 
in the lungs and to cause bladder and stomach cancer in mice 
[Kondo et al., 2008]. Agaritine content decreases during pres-
ervation. Storage at 5ºC reduced its content to 25% and 50% 
after 6  and  14  days, respectively [Schulzová et  al., 2002]. 
However, this compound displays the antiviral activity, e.g. as 
a potent inhibitor of HIV protease [Sorimachi & Koge, 2008].
Fruiting bodies of  Agaricus bisporus as a  source 
of vitamins
White mushroom is a rich source of vitamins, especially 
the B-group vitamins (B1, B2, B3, niacin, folates, B12), and vi-
tamin D2 − provitamin ergosterol, and ergocalciferol [Kalbar-
czyk & Radzki, 2009]. This species is also a good source of vi-
tamin C (17 mg/100 g D.W.) [Bernaś et al., 2006b; Kalbarczyk 
& Radzki, 2009]. The content of vitamins varies depending 
on mushroom growing conditions (including environmental 
factors). A. bisporus contains ergosterol – a precursor of vi-
tamin D2 (ergocalciferol), which is necessary for sustaining 
the  appropriate calcium-phosphate balance in  the  human 
organism. Ergosterol content in  fruiting bodies of A. bispo-
rus is usually reported to range from 61.5 mg/100 g of D.W. 
[Muszyńska et al., 2013a] to 186.1 mg/100 g D.W. [Heleno 
et  al., 2016]. The  high levels of  this substance make white 
mushroom a rich source of vitamin D for vegetarians and veg-
ans [Muszyńska et al., 2013a]. There have been experiments 
designed to enrich A. bisporus with vitamin D2 via irradiation 
with UV-B and UV-C light [Koyalamudi et al., 2009; Roberts 
et al., 2008]. Their results seem to be promising in the preven-
tion of common vitamin D defi ciencies, including in Poland. 
Detailed information about the content of vitamins in fruiting 
bodies of A. bisporus is presented in Table 1.
Fruiting bodies of A. bisporus as a  source of macro- 
and microelements 
The fact that mushrooms are able to accumulate elements 
from the environment explains their attractiveness for research-
ers. Bioelements that are absorbed by some mushroom species 
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act as enzyme activators or are their structural parts. The most 
important mechanism of accumulation of elements in mush-
rooms is based on binding by metallothionein – a low-molec-
ular-weight protein, which has an affi nity especially for metals. 
Elements can also be  found in mushroom dyes. Numerous 
researchers have also confi rmed the presence of copper, mag-
nesium, iron, sodium, potassium, calcium, phosphorus, zinc, 
lithium, titanium, barium, strontium, selenium, cadmium, lead, 
chromium, and nickel. The content of these elements is shown 
in  Table 1. White mushroom is  a  rich source of  selenium 
and  zinc. These elements demonstrate antioxidant abilities, 
due to which mushrooms can prevent oxidation of unsaturated 
fatty acids. Selenium levels can be as high as 0.5 mg/100 g D.W. 
[Falandysz & Borovička, 2013; Yilmaz et al., 2006]. Zinc is vital 
for protein synthesis, an important component of digestive en-
zymes, and is involved in insulin storage and in the activation 
of more than 300 enzymes. According to the  literature data, 
TABLE 1. Content of biologically-active substances in A. bisporus fruiting bodies.























































































































































































































































































D.W. – dry weight, F.W. fresh weight.
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zinc content in fruiting bodies of Agaricus species ranges from 
7.5 to 15 mg/100 g D.W. [Kalač, 2010]. The daily requirement 
for this element in a healthy adult human is dependent on age 
and is about 15 mg [Johnson, 2003]. The levels of zinc released 
from fruiting bodies and biomass from in vitro cultures of A. 
bisporus have been established. A maximum of 2 mg Zn/100 g 
D.W. are released from fruiting bodies of A. bisporus to artifi -
cial digestive juices, whereas the total amount of zinc released 
from biomass of  A. bisporus obtained from in  vitro culture 
averages 10 mg/100  g D.W. The highest total concentration 
of this element released into artifi cial digestive juices has been 
found in biomass of A. bisporus cultures on the  culture me-
dium with the addition of 200 mg/L zinc hydroaspartate (up to 
57 mg/100 g D.W.) [Muszyńska et al., 2015a]. The levels of ele-
ments in extracts of fruiting bodies of A. bisporus are presented 
in Table 1.
BIOLOGICAL ACTIVITY OF FRUITING BODIES 
OF AGARICUS BISPORUS
Anti-carcinogenic and  antioxidant properties 
of substances found in fruiting bodies of A. bisporus
Free radicals usually found in  the human organism can 
lead to the development of many civilization diseases, such 
as cancer or cardiovascular disease. Oxidative stress and free 
radical production can be caused by diseases, long periods 
of stress or natural aging. There are internal natural mech-
anisms in  the  human organism that can prevent oxidative 
stress, such as the production of free radical species – super-
oxide dismutase (SOD) or catalase [Elmastas et al., 2007; Hu 
et al., 2015; Maseko et al., 2014; Tsai et al., 2008]. These natu-
ral mechanisms should be  aided by  providing antioxidants 
with food. As a  source of  antioxidants, A. bisporus has for 
many years been examined for the potential preventive action 
in  hypertension, hypercholesterolemia or cancer [Elmastas 
et al., 2007; Tsai et al., 2008]. Due to their acetylcholinester-
ase and butyrylcholinesterase inhibiting activity, A. bisporus 
extracts can be  potentially applied in  Alzheimer’s disease 
treatment [Öztürk et al., 2011].
Apart from its occurrence in  the  natural environment, 
white mushroom is widely grown on organic substrates. Meth-
anol extracts from this species have been examined for antioxi-
dant activity derived from high concentrations of α-tocopherol 
and these have also revealed the presence of β-carotene [Tsai 
et al., 2008]. The antioxidant effect of A. bisporus is strongly 
correlated with substances found in  this mushroom that act 
as reducers in many chemical reactions, and that are able to 
scavenge free radicals or chelate metal ions [Elmastas et al., 
2007; Glamočlija et al., 2015; Vamanu & Nita, 2014]. The role 
of A. bisporus fruiting body extracts in the prevention of some 
cancer types such as breast cancer or prostate cancer has been 
researched and confi rmed. The main substances responsible 
for this action are phenol compounds, lectins, β-glucans, ar-
ginine, ergothioneine and fatty acids (80% of total fatty acid 
amount are unsaturated fatty acids). This is important, because 
a defi ciency in these substances in the diet can be the causative 
agent of many diseases, such as cancer or circulatory system 
diseases [Ahmad et al., 2013; Novaes et al., 2011; Öztürk et al., 
2011; Patel & Goyal, 2012; Yilmaz et al., 2006].
A. bisporus is a rich source of  fatty acids such as palmitic 
acid, linoleic acid, linolenic acid that can prevent the develop-
ment of breast cancer [Öztürk et al., 2011]. This action involves 
inhibition of aromatase and consequently – synthesis of estro-
gens – hormones that play an important role in breast cancer 
development. The  latest clinical research has shown that aro-
matase inhibitors are effective in  hormone-dependent mam-
mary cancer treatment [Patel & Goyal, 2012; Chen et al., 2006]. 
In research conducted by Chen et al. [2006], A. bisporus extracts 
were the most effective aromatase inhibitors, when compared 
with seven other plant extracts. Phenolic acids isolated from 
A. bisporus, including hydroxybenzoic acid and protocatechuic 
acid, are also characteristic for this species. These substances, 
apart from their typical anti-carcinogenic activity, also show an-
tioxidant and anti-infl ammatory actions [Siwulski et al., 2014]. 
The  application of A. bisporus to anticancer therapy should, 
therefore, be feasible and inexpensive [Chen et al., 2006].
The  anti-carcinogenic activity can also be  observed for 
ergosterol found in the Agaricales taxon. This can provide an-
ti-carcinogenic activity via inhibiting the metaplastic cell mi-
gration and proliferation. Ergosterol can also inhibit angio-
genesis. In patients treated with ergosterol, a delay in tumor 
growth has been obtained along with minimal side effects. 
In  patients under chemotherapy, extracts rich in  ergosterol 
did not induce any adverse effects on the level of lymphocytes 
[Novaes et al., 2011].
Antimicrobial and antiviral activity of Agaricus bisporus
The  ethanolic extract of  fruiting bodies of  A. bisporus 
contains various components with antimicrobial activity. 
The freeze-dried extract of this species displays activity towards 
Escherichia coli CBAB 2 (Minimum Inhibitory Concentration 
– MIC – 5 mg/mL), and also against Staphylococcus aureus 
ATCC 6588 (Gram negative). On the other hand, Pseudomonas 
aeruginosa ATCC 15442 has proved to be  the most resistant 
strain, with a MIC value of 15 mg/mL [Vamanu, 2012].
The antimicrobial action of numerous mushroom species 
(including A. bisporus) is due to high contents of  chitosan 
and chitin. Chitin and its deacetylated derivative – chitosan, 
are polysaccharides whose molecular weight is relatively high 
(similar to the ones found in crustaceans), which could sug-
gest that their antibacterial properties are reduced. The an-
timicrobial effect of chitin and  its derivatives increases with 
a decrease in the molecular weight. The activity is based on 
decreasing bacterial adhesion to the culture medium [Rajew-
ska et al., 2004]. Research into Agaricus campestris, a species 
closely related to A. bisporus, has shown the presence of aga-
rodoxin – a benzoquinone derivate. This substance is an anti-
biotic and shows activity against Staphylococcus aureus (gold-
en staph) [Muszyńska et al., 2011]. A. bisporus, on the other 
hand, shows activity against Micrococcus luteus, Micrococcus 
fl avus, Bacillus subtilis, Bacillus cereus, Candida albicans, 
and Candida tropicalis [Öztürk et al., 2011].
CONCLUSION
The  fruiting bodies of  Agaricus bisporus, which is  one 
of  the  most commonly cultivated and  consumed mush-
rooms, are a good source of many substances with biological 
B. Muszyńska et al. 179
activity. Because of its ability to accumulate physiologically-
active compounds, metals and  vitamins, A. bisporus is not 
only a very popular delicacy but also an effective additive for 
the human diet. Due to high contents of bioelements and or-
ganic compounds essential for humans, its fruiting bodies 
consumption provides a high nutritional value. A. bisporus 
also contains substances that are well known for decreasing 
blood sugar levels and changing lipid profi les. Additionally, 
it has anti-carcinogenic, antioxidant, antibacterial, and anti-
viral properties. Determination of ergothioneine and tyrosi-
nase in  fruiting bodies has partially explained their activi-
ties and has made this species a signifi cant mushroom with 
a medical and nutritional value. 
Until today, numerous researches have been conducted 
in a model of  the human digestive tract. These experiments 
showed that the  fruiting bodies and biomass of  in vitro cul-
tures of A. bisporus release physiologically-active substances 
to artifi cial digestive juices. The next stage of research should 
be  to determine the absorption level of  the  examined com-
pounds which were previously released to artifi cial diges-
tive juices. For this reason, our future research will address 
the precise determination of released substances and estab-
lishing the percent in which these physiologically-active com-
pounds are absorbed by passive and active transport.
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